Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Men with early hair loss may have higher health risks similar to women with PCOS.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

Leucine levels may affect hair loss after bariatric surgery.

Radiofrequency treatment helps rejuvenate skin by boosting collagen and blood vessel growth.

Adipokines affect skin health and could be targeted for treating skin diseases.

Nanotechnology in skincare improves ingredient stability, skin penetration, and controlled release for better cosmetic solutions.

The FGF5 gene variant causes long hair in Akitas, and genetic testing is advised to manage coat length and welfare.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

A specific gene mutation causes congenital hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Photobiomodulation is safe and effective for treating certain conditions like nerve pain and hair loss.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Women with PCOS have a higher risk of heart disease.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

The new omeprazole nanoemulgel shows promise as a topical treatment for infections.